Filter
2513
Filtered Results: 2513
Text search:
Global
TB
Programme
Featured
Recommendations
205
New Publications
691
Language
Document type
No document type
1613
Studies & Reports
388
Guidelines
252
Strategic & Response Plan
93
Manuals
87
Fact sheets
29
Training Material
21
Situation Updates
16
Infographics
8
Resource Platforms
5
Brochures
1
Countries / Regions
India
107
Global
94
Kenya
82
South Africa
82
Western and Central Europe
71
Zambia
59
Malawi
51
Nepal
50
Tanzania
49
Uganda
49
Sierra Leone
48
Namibia
46
Nigeria
45
Eastern Europe
44
Africa
43
Ghana
42
Myanmar / Burma
42
Ethiopia
41
Lesotho
34
Bangladesh
33
Senegal
31
Liberia
29
Asia
28
Ukraine
27
Rwanda
25
South–East Asia Region
25
Congo, Democratic Republic of
24
Zimbabwe
22
Cambodia
18
Latin America and the Carribbean
16
Burkina Faso
14
Benin
13
Mozambique
13
South Sudan
13
Indonesia
13
Haiti
12
Russia
12
Cameroon
11
East and Southern Africa
11
Central African Republic
10
Botswana
10
Pakistan
10
Syria
9
Philippines
9
Madagascar
9
Colombia
8
Guinea
8
Albania
7
Tajikistan
6
Armenia
6
West and Central Africa
6
Middle East and North Africa
6
Georgia
6
Eswatini/ Swaziland
6
Sudan
5
Yemen
5
Afghanistan
4
Burundi
4
Venezuela
4
Western Pacific Region
4
Eastern Europe and Central Asia
4
Bolivia
4
Brazil
4
Laos
3
Peru
3
Jordan
3
Germany
3
Southern Africa
3
Argentina
3
Lebanon
3
Moldova
3
Sri Lanka
3
Somalia
3
North Macedonia
2
Timor Leste/ East Timor
2
Thailand
2
El Salvador
2
Iran
2
Niger
2
Morocco
2
Saudi Arabia
2
Vietnam
2
Angola
2
Bhutan
2
Iraq
2
North Korea
1
Mexico
1
Turkey
1
Gambia
1
Togo
1
Qatar
1
Bulgaria
1
Guinea-Bissau
1
Ireland
1
Paraguay
1
North America
1
Gabon
1
Uruguay
1
Turkmenistan
1
Jamaica
1
Belgium
1
Maldives
1
Tunisia
1
Spain
1
Belarus
1
Côte d’Ivoire / Ivory Coast
1
Nicaragua
1
Djibouti
1
Egypt
1
Romania
1
Greece
1
Palestine
1
Honduras
1
Mali
1
Chad
1
Libya
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1069
Clinical Guidelines
172
Public Health
109
Key Resources
65
Women & Child Health
64
Pharmacy & Technologies
31
Capacity Building
25
Toolboxes
TB
502
HIV
396
AMR
94
COVID-19
82
NTDs
56
Mental Health
51
Health Financing Toolbox
48
Caregiver
46
Global Health Education
44
Disability
38
NCDs
34
Refugee
28
Ebola & Marburg
28
Conflict
27
Planetary Health
23
Pharmacy
23
Rapid Response
19
Polio
16
Natural Hazards
13
Malaria
13
Zika
4
Social Ethics
3
Specific Hazards
2
South Sudan
1
Cholera
1
The World health statistics report is the annual compilation of health and health-related indicators, which has been published by the World Health Organization since 2005.
The 2025 edition consolidates data for health-related indicators from the Sustainable Development Goals. It assesses progres...
2016-2018 Early implementation,
This report presents 2015 data on the consumption of systemic antibiotics from 65 countries and areas, contributing to our understanding of how antibiotics are used in these countries. In addition, the report documents early efforts of the World Health Organization (...
Antimicrobial resistance (AMR) is described as a situation when bacteria, viruses, fungi and parasites
change over time and no longer respond to medicines, making infections harder or impossible to treat,
and increasing the risk of disease spread, severe illness and death.1 AMR in recent years has...
The manual is written for clinicians working at the district hospital (first-level referral care) who diagnose and manage sick adolescents and adults in resource constrained settings. It aims to support clinical reasoning, and to provide an effective clinical approach and protocols for the managemen...
The World Health Organization's fourth Country Cooperation Strategy 2022-2026 is an outcome of a consultative process with inputs from the Ministry of Health, various agencies in the health sector, and other relevant stakeholders. It has been developed to provide strategic direction and support towa...
Vitamin D deficiency is thought to be common among pregnant women, particularly during the winter months, and has been found to be associated with an increased risk of pre-eclampsia, gestational diabetes mellitus, preterm birth, and other tissue-specific conditions.
This guideline is intended for ...
This manual for developing national action plans to address antimicrobial resistance has been developed at the request of the World Health Assembly to assist countries in the initial phase of developing new, or refining existing national action plans in line with the
strategic objectives of the Glo...
Climate change is a growing concern for Bangladesh because 90 percent of the country is approximately 10 feet above sea level. An evaluation was completed which discovered that high tides in Bangladesh were increasing 10 times more rapidly than the global average. This predicted rapid increase in se...
This document aims to provide interim guidance for microbiology and virology experts, other laboratory professionals, laboratory managers, infectious disease programme managers, public health professionals and other stakeholders that provide primary, confirmatory or advanced testing for SARS-CoV-2, ...
A manual for developing national action plans.This manual for developing national action plans to address antimicrobial resistance has been developed at the request of the World Health Assembly to assist countries in the initial phase of developing new, or refining existing national action plans in ...
The meeting was held from 26 to 27 March 2018 to review and discuss the following topics:
Advances and challenges in the use of fTLC, and new approaches to detecting mycolactone using monoclonal antibodies (mAbs).
The status of development of rapid diagnostic tests (RDTs) targeting the MUL...
Modelling the health impacts of disruptions to essential health services during COVID-19 Module 1
Several epidemiological models have been created to assess the potential impact of disruptions to essential health services caused by COVID-19 on morbidity and mortality from conditions other than COVI...
The toolbox contains guidance and tools (sample templates) for data collection in M&E of PSS programmes. The tools can be adapted to PSS programme, depending upon target group, activities and scope. These are tools that may be useful for your programme and many are drawn from existing PSS programme ...
Atlas of African Health Statistics 2022: Health situation analysis of the WHO African Region
Since 2019, we have been implementing Phase 2 of the regional Transformation Agenda, which informs and aligns with the global WHO Transformation, to ensure WHO is accountable, driven by re- sults and provid...
Non-Communicable Diseases (NCDs), including mental disorders, currently pose one of the biggest threats to health and development globally, particularly in low and middle income countries2. It is predicted that unless proven interventions are rapidly implemented in countries, in the short to medium ...
A guide to increasing coverage and equity in all communities in the African Region
Expanded Programs on Immunization (EPI) is responsible for vaccines and vaccination to control, eliminate and eradicate vaccine preventable diseases (VPDs). Having strong immunization systems to deliver vaccines ...
Expanded Programs on Immunization (EPI) is responsible for vaccines and vaccination to control, eliminate and eradicate vaccine preventable diseases (VPDs). Having strong immunization systems to deliver vaccines ...
Asthma is the most common non-communicable disease in children and remains one of the most common throughout the life course. The great majority of the burden of this disease is seen in low-income and middle-income countries (LMICs), which have disproportionately high asthma-related mortality relati...
Spread of resistance to antimicrobial agents (AMR) does not know national borders and has reached dimensions, which require immediate actions at the national, regional and global levels.
Antibiotic resistance is a natural biological response to improper use of antimicrobial agents (AMA); increasing...
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID-19 doses, stimulated new resolve to address future...
